In last trading session, Onconetix Inc (NASDAQ:ONCO) saw 0.46 million shares changing hands with its beta currently measuring 3.17. Company’s recent per share price level of $0.54 trading at -$0.02 or -3.66% at ring of the bell on the day assigns it a market valuation of $7.92M. That closing price of ONCO’s stock is at a discount of -3862.96% from its 52-week high price of $21.40 and is indicating a premium of 40.74% from its 52-week low price of $0.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 19.37 million shares which gives us an average trading volume of 8.91 million if we extend that period to 3-months.

Onconetix Inc (NASDAQ:ONCO) trade information

Upright in the red during last session for losing -3.66%, in the last five days ONCO remained trading in the green while hitting it’s week-highest on Monday, 01/27/25 when the stock touched $0.54 price level, adding 48.08% to its value on the day. Onconetix Inc’s shares saw a change of -13.62% in year-to-date performance and have moved 13.38% in past 5-day. Onconetix Inc (NASDAQ:ONCO) showed a performance of 24.53% in past 30-days. Number of shares sold short was 33333.0 shares which calculate 0.45 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -116.38% during past 5 years.

On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 4.04 shares of worth $2197.0 or 0.05% of the total outstanding shares. The later fund manager was in possession of 1.84 shares on Sep 30, 2024 , making its stake of worth around $999.0 in the company or a holder of 0.02% of company’s stock.